End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4384 USD | +2.62% | +3.89% | -10.00% |
04-30 | Akili, Inc. Plans to Continue to Pursue Marketing Authorization from the U.S. Food and Drug Administration for Its EndeavorOTC Product | CI |
04-30 | Akili, Inc. to Reduce Workforce | CI |
- Stock Market
- Equities
- AKLI Stock
- News Akili, Inc.
- Analyst Reco.